Cell to Cure ApS

Cell to Cure ApS is dedicated to pioneering advancements in biotechnology, with a focus on developing innovative stem cell products designed to revolutionize disease treatment. Cell to Cure ApS is committed to providing patients, physicians, and healthcare systems worldwide with accessible, highly effective, and safe “off-the-shelf” stem cell solutions for a broad spectrum of conditions. Located at Henrik Harpestrengs Vej 4c, 9302, Copenhagen, DK2100, DK, Cell to Cure is at the forefront of therapeutic innovation.

Cell to Cure is actively developing stem cell products that are integrated into promising new therapeutic approaches for various diseases. Extensive pre-clinical studies, along with Phase I and Phase II clinical trials, have showcased the potential of their stem cell products in treating heart diseases and promoting tissue regeneration. These products are currently undergoing clinical testing for a wide array of indications where inflammation and tissue regeneration are critical, including the prevention of organ transplant rejection.

Cell to Cure ApS envisions a future where stem cell therapies are readily available and contribute significantly to improving patient outcomes. The company’s commitment to research and development positions it as a key player in the biotechnology sector. We invite the manager of Cell to Cure ApS to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform.